DRD2 Antilichaam / Dopamine D2 Receptor

This gene encodes the D2 subtype of the dopamine receptor. This G-protein coupled receptor inhibits adenylyl cyclase activity. A missense mutation in this gene causes myoclonus dystonia; other mutations have been associated with schizophrenia. Alternative splicing of this gene results in two transcript variants encoding different isoforms. A third variant has been described, but it has not been determined whether this form is normal or due to aberrant splicing.

Western blot: 1:1000-1:2000

P14416

Human

A portion of amino acids 307-336 from the human protein were used as the immunogen for the DRD2 antibody.

WB

Antigen affinity purified

Purified

This DRD2 antibody is available for research use only.

Aliquot the DRD2 antibody and store frozen at -20°C or colder. Avoid repeated freeze-thaw cycles.

In 1X PBS, pH 7.4, with 0.09% sodium azide

The stated application concentrations are suggested starting points. Titration of the DRD2 antibody may be required due to differences in protocols and secondary/substrate sensitivity.

Western blot testing of human 1) brain, 2) cerebellum, 3) HT-1080 and 4) K562 lysate with DRD2 antibody. Predicted molecular weight ~51 kDa.